Ole Christian Lingjærde

机构：Oslo University Hospital, University of Oslo · ORCID：0000-0003-3565-4912

发表论文 484 篇 · 总被引 29088 次 · h-index 64

代表论文

• Comprehensive multi-omics analysis of breast cancer reveals distinct long-term prognostic subtypes (2024 · Oncogenesis · 被引 46)
• Transcriptomic subtyping of malignant peripheral nerve sheath tumours highlights immune signatures, genomic profiles, patient survival and therapeutic targets (2023 · EBioMedicine · 被引 31)
• Gut microbiota diversity is prognostic and associated with benefit from chemo‐immunotherapy in metastatic triple‐negative breast cancer (2024 · Molecular Oncology · 被引 24)
• Ipilimumab and nivolumab combined with anthracycline-based chemotherapy in metastatic hormone receptor-positive breast cancer: a randomized phase 2b trial (2024 · Journal for ImmunoTherapy of Cancer · 被引 18)
• Multi-omics profiling of longitudinal samples reveals early genomic changes in follicular lymphoma (2024 · Blood Cancer Journal · 被引 11)
• Deep learning for automated scoring of immunohistochemically stained tumour tissue sections – Validation across tumour types based on patient outcomes (2024 · Heliyon · 被引 6)